Table 1.
Details of Data Sources Included in the Study
| Diseases | Data source | Population | Sample size (cases/controls) | Covariates adjusted in GWAS |
|---|---|---|---|---|
| Anemia | FinnGen | European | 19 885/76464 | Age, sex, and genotyping batch |
| Heart failure | HERMES | European | 47 309/930014 | Age, sex, and principal components |
| Atrial fibrillation | AFGen | European | 60 620/970216 | Birth year, sex, and genotype batch |
| Coronary artery disease | CARDIoGRAMplusC4D | Mixed | 60 801/123504 | Sex, age, and generation |
| Any stroke | MEGASTROKE | European | 40 585/406111 | Age, sex |
| Any ischemic stroke | MEGASTROKE | European | 34 217/406111 | Age, sex |
AFGen indicates Atrial Fibrillation Genetics; CARDIoGRAMplusC4D, Coronary Artery Disease Genome‐Wide Replication and Meta‐Analysis Plus the Coronary Artery Disease Genetics; FinnGen, FinnGen consortium; GWAS, genome‐wide association study; HERMES, Heart Failure Molecular Epidemiology for Therapeutic Targets; and MEGASTROKE, MEGASTROKE consortium.